CD 130 (Ranitidine Hydrochloride 300 mg)
Pill with imprint CD 130 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Dr. Reddy’s Laboratories Inc.
Ranitidine is used in the treatment of duodenal ulcer; erosive esophagitis; cutaneous mastocytosis; duodenal ulcer prophylaxis; gerd and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CD 130
Ranitidine Hydrochloride
- Imprint
- CD 130
- Strength
- 300 mg
- Color
- Brown
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy’s Laboratories Inc.
- Inactive Ingredients
-
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
ferrosoferric oxide,
ferric oxide red,
ferric oxide yellow,
titanium dioxide,
gelatin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 55111-0130 (Discontinued) | Dr. Reddy's Laboratories, Inc. |
| 42291-0736 (Discontinued) | AvKare, Inc. |
Related Images for "CD 130"
More about ranitidine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (156)
- Patient tips
- Drug images
- Compare alternatives
- Drug class: H2 antagonists
Patient resources
- Drug Information
- Ranitidine Injection
- Ranitidine Tablets and Capsules
- Ranitidine Suspension
- Ranitidine Syrup
- Other brands
- Zantac
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.